Cagrilintide

Cagrilintide is a long-acting analogue of amylin, a hormone co-secreted with insulin from pancreatic beta cells. This modified peptide has an extended half-life compared to native amylin. Researchers study Cagrilintide for its effects on appetite regulation, gastric emptying, and metabolic control in laboratory models.

Research on Cagrilintide examines its effects on appetite suppression and metabolic regulation. Studies focus on its influence on food intake, gastric emptying rate, glucagon secretion, and body weight regulation. Researchers investigate its mechanisms involving amylin receptor activation, central nervous system appetite pathways, and synergistic effects with other metabolic hormones in experimental settings.